USPTO serial 79018738
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,300
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1100 New York Avenue, N.W.Washington, DC 20005UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; veterinary preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; biotechnology preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; medical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; diagnostic preparations and reagents for medical purposes; culture fluids, namely, cultures of micro-organisms for medical purposes; human allograft tissue; animal allograft tissue; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes; human cells including stem cells, animal cells including stem cells for medical or clinical use; pharmaceutical preparations for the treatment, reconstruction and repair of tissue | ACTIVE | — |
| 042 | Scientific, medical research, clinical research, pharmaceutical research and development, advisory and consultancy services in the field of T-cell production, T-cell immunotherapy, cell culture devices, tissue engineering for cellular applications for humans and animals, stem cell banking, tissue banking, drug discovery, vaccine screening, cell culture methods, cell expansion technology including stem cell expansion technology, cellular therapies including stem cell therapies and cellular transplants | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 26, 2026 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 11, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 3, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Aug 10, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 10, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Aug 7, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jul 7, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 25, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 25, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 7, 2016 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jul 17, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 16, 2015 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Nov 29, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2013 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 21, 2013 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Mar 21, 2013 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jan 15, 2013 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Jan 15, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 24, 2012 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 24, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 23, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 26, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 5, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 5, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 19, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 7, 2007 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 7, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 1, 2007 | PAPER RECEIVED | — | |
| Jun 14, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 31, 2007 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2007 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 22, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 22, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 22, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 22, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 22, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2007 | ALIE | ASSIGNED TO LIE | — |
| Feb 16, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2007 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 16, 2007 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 16, 2007 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 17, 2006 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 16, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 19, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 17, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 12, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 11, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 30, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |